{"id":"https://openalex.org/W7225007416","doi":"https://doi.org/10.38029/babcockuniv.med.j..v9is1.1653","title":"Neuregulin-4 as a novel target of dapagliflozin in high-fat diet-induced fatty liver disease in rats","display_name":"Neuregulin-4 as a novel target of dapagliflozin in high-fat diet-induced fatty liver disease in rats","publication_year":2026,"publication_date":"2026-10-31","ids":{"openalex":"https://openalex.org/W7225007416","doi":"https://doi.org/10.38029/babcockuniv.med.j..v9is1.1653"},"language":"en","primary_location":{"id":"doi:10.38029/babcockuniv.med.j..v9is1.1653","doi":"https://doi.org/10.38029/babcockuniv.med.j..v9is1.1653","is_oa":true,"landing_page_url":"https://doi.org/10.38029/babcockuniv.med.j..v9is1.1653","pdf_url":"https://bumj.babcock.edu.ng/index.php/bumj/article/download/1653/446","source":{"id":"https://openalex.org/S4210169780","display_name":"Babcock University Medical Journal","issn_l":"2465-6666","issn":["2465-6666","2756-4657"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","jpps-1"],"host_organization":"https://openalex.org/I30887324","host_organization_name":"Babcock University","host_organization_lineage":["https://openalex.org/I30887324"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Babcock University Medical Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://bumj.babcock.edu.ng/index.php/bumj/article/download/1653/446","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160266529","display_name":"Hiba ALkarawi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166455938","display_name":"University of Babylon","ror":"https://ror.org/0170edc15","country_code":"IQ","type":"education","lineage":["https://openalex.org/I166455938"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Hiba ALkarawi","raw_affiliation_strings":["Department of Pharmacology and Toxicology, College of Medicine, University of Babylon, Hillah, Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, College of Medicine, University of Babylon, Hillah, Iraq","institution_ids":["https://openalex.org/I166455938"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5093632106","display_name":"Fatima Alzubaidi","orcid":"https://orcid.org/0009-0001-4384-2510","observed_orcids":["https://orcid.org/0009-0001-4384-2510"]},"institutions":[{"id":"https://openalex.org/I166455938","display_name":"University of Babylon","ror":"https://ror.org/0170edc15","country_code":"IQ","type":"education","lineage":["https://openalex.org/I166455938"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Fatima Alzubaidi","raw_affiliation_strings":["Department of Pharmacology and Toxicology, College of Pharmacy, University of Babylon, Hillah, Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, College of Pharmacy, University of Babylon, Hillah, Iraq","institution_ids":["https://openalex.org/I166455938"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I166455938"],"apc_list":{"value":45000,"currency":"NGN","value_usd":null},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.85940996,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"9","issue":"S1","first_page":"259","last_page":"271"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/neuregulin-4","display_name":"neuregulin 4","score":0.9269999861717224},{"id":"https://openalex.org/keywords/hepatic-steatosis","display_name":"hepatic steatosis","score":0.9039999842643738},{"id":"https://openalex.org/keywords/high-fat-high-fructose-diet","display_name":"high-fat high-fructose diet","score":0.8550000190734863},{"id":"https://openalex.org/keywords/hepatoprotective-effect","display_name":"hepatoprotection","score":0.921999990940094},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.9179999828338623},{"id":"https://openalex.org/keywords/antioxidant-status","display_name":"antioxidant status","score":0.9259999990463257},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.9049999713897705},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9700000286102295},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.8450000286102295}],"concepts":[{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.842199981212616},{"id":"https://openalex.org/C2776175330","wikidata":"https://www.wikidata.org/wiki/Q1365091","display_name":"Steatosis","level":2,"score":0.6988000273704529},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.685699999332428},{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.6793000102043152},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6488999724388123},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6435999870300293},{"id":"https://openalex.org/C2778401633","wikidata":"https://www.wikidata.org/wiki/Q418661","display_name":"Malondialdehyde","level":3,"score":0.6401000022888184},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.6148999929428101},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.5008999705314636},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.48089998960494995},{"id":"https://openalex.org/C125473707","wikidata":"https://www.wikidata.org/wiki/Q9914","display_name":"H&E stain","level":3,"score":0.39739999175071716},{"id":"https://openalex.org/C2778004101","wikidata":"https://www.wikidata.org/wiki/Q133948","display_name":"Antioxidant","level":2,"score":0.36239999532699585},{"id":"https://openalex.org/C2993667909","wikidata":"https://www.wikidata.org/wiki/Q147778","display_name":"Hepatic fibrosis","level":3,"score":0.3569999933242798},{"id":"https://openalex.org/C538909803","wikidata":"https://www.wikidata.org/wiki/Q116907","display_name":"Glutathione","level":3,"score":0.3463999927043915},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3174999952316284},{"id":"https://openalex.org/C2779102576","wikidata":"https://www.wikidata.org/wiki/Q5113984","display_name":"Chronic liver disease","level":3,"score":0.31290000677108765},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.30970001220703125},{"id":"https://openalex.org/C2776954865","wikidata":"https://www.wikidata.org/wiki/Q1546498","display_name":"Nonalcoholic fatty liver disease","level":4,"score":0.29510000348091125},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.2939999997615814},{"id":"https://openalex.org/C2908939727","wikidata":"https://www.wikidata.org/wiki/Q970208","display_name":"Hepatic dysfunction","level":2,"score":0.29089999198913574},{"id":"https://openalex.org/C2777075537","wikidata":"https://www.wikidata.org/wiki/Q929737","display_name":"Liver disease","level":2,"score":0.28780001401901245},{"id":"https://openalex.org/C2992872382","wikidata":"https://www.wikidata.org/wiki/Q305481","display_name":"Alanine aminotransferase","level":2,"score":0.28610000014305115},{"id":"https://openalex.org/C544855455","wikidata":"https://www.wikidata.org/wiki/Q1070952","display_name":"Histopathology","level":2,"score":0.2831999957561493},{"id":"https://openalex.org/C2778760513","wikidata":"https://www.wikidata.org/wiki/Q24773045","display_name":"Glutathione peroxidase","level":4,"score":0.27799999713897705},{"id":"https://openalex.org/C2778606649","wikidata":"https://www.wikidata.org/wiki/Q305481","display_name":"Alanine transaminase","level":2,"score":0.26579999923706055},{"id":"https://openalex.org/C163031210","wikidata":"https://www.wikidata.org/wiki/Q3325848","display_name":"Masson's trichrome stain","level":3,"score":0.26100000739097595}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.38029/babcockuniv.med.j..v9is1.1653","doi":"https://doi.org/10.38029/babcockuniv.med.j..v9is1.1653","is_oa":true,"landing_page_url":"https://doi.org/10.38029/babcockuniv.med.j..v9is1.1653","pdf_url":"https://bumj.babcock.edu.ng/index.php/bumj/article/download/1653/446","source":{"id":"https://openalex.org/S4210169780","display_name":"Babcock University Medical Journal","issn_l":"2465-6666","issn":["2465-6666","2756-4657"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","jpps-1"],"host_organization":"https://openalex.org/I30887324","host_organization_name":"Babcock University","host_organization_lineage":["https://openalex.org/I30887324"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Babcock University Medical Journal","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.38029/babcockuniv.med.j..v9is1.1653","doi":"https://doi.org/10.38029/babcockuniv.med.j..v9is1.1653","is_oa":true,"landing_page_url":"https://doi.org/10.38029/babcockuniv.med.j..v9is1.1653","pdf_url":"https://bumj.babcock.edu.ng/index.php/bumj/article/download/1653/446","source":{"id":"https://openalex.org/S4210169780","display_name":"Babcock University Medical Journal","issn_l":"2465-6666","issn":["2465-6666","2756-4657"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","jpps-1"],"host_organization":"https://openalex.org/I30887324","host_organization_name":"Babcock University","host_organization_lineage":["https://openalex.org/I30887324"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Babcock University Medical Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225007416.pdf","grobid_xml":"https://content.openalex.org/works/W7225007416.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1589430668","https://openalex.org/W1978804351","https://openalex.org/W1988747367","https://openalex.org/W2091330563","https://openalex.org/W2095015649","https://openalex.org/W2099841055","https://openalex.org/W2114352928","https://openalex.org/W2158594746","https://openalex.org/W2167898988","https://openalex.org/W2170061748","https://openalex.org/W2293932895","https://openalex.org/W2506843278","https://openalex.org/W2518904228","https://openalex.org/W2721080306","https://openalex.org/W2740703783","https://openalex.org/W2809595382","https://openalex.org/W2810729752","https://openalex.org/W2921017081","https://openalex.org/W3037653703","https://openalex.org/W3080857839","https://openalex.org/W3154897461","https://openalex.org/W4315433967","https://openalex.org/W4366978333","https://openalex.org/W4403945755","https://openalex.org/W4411933942"],"related_works":["https://openalex.org/W4401495879","https://openalex.org/W4205105466","https://openalex.org/W7220444031","https://openalex.org/W3014490433","https://openalex.org/W4364353556","https://openalex.org/W4311284128","https://openalex.org/W3037653703","https://openalex.org/W2989691439","https://openalex.org/W4292484706","https://openalex.org/W4387033605"],"abstract_inverted_index":{"Objective:":[0],"The":[1,126,218],"present":[2],"study":[3],"aimed":[4],"to":[5,23,191,240],"evaluate":[6],"the":[7,82,152,229,242],"hepatoprotective":[8,230],"effects":[9,189,231],"of":[10,16,204,226,232],"dapagliflozin":[11,70,157],"in":[12,180,185,216,228],"a":[13,177,213,223],"rat":[14],"model":[15],"high-fat/high-fructose":[17,49,214],"diet-induced":[18],"fatty":[19],"liver":[20,160],"disease":[21],"and":[22,62,69,79,90,103,112,119,121,139,147,169,183,208],"investigate":[24],"its":[25],"association":[26],"with":[27,144,151,156,188,194,202,222],"Neuregulin-4":[28],"(NRG4)":[29],"expression.":[30],"Methods:":[31],"Forty":[32],"adult":[33],"male":[34],"Wistar":[35],"albino":[36],"rats":[37],"were":[38,71,94,106,115],"randomly":[39],"allocated":[40],"into":[41],"five":[42],"groups":[43],"(n":[44],"=":[45],"8":[46],"each):":[47],"control,":[48],"diet":[50,215],"(HFD),":[51],"pioglitazone-treated":[52],"(10":[53],"mg/kg/day":[54,59],"+":[55,60,66],"HFD),":[56,61],"dapagliflozin-treated":[57,186],"(1":[58],"vehicle-treated":[63],"(1%":[64],"DMSO":[65],"HFD).":[67],"Pioglitazone":[68],"administered":[72],"orally":[73],"for":[74],"14":[75],"days":[76],"before":[77],"induction":[78,84],"continued":[80],"throughout":[81],"8-week":[83],"period.":[85],"Serum":[86],"alanine":[87],"aminotransferase":[88,92],"(ALT)":[89],"aspartate":[91],"(AST)":[93],"measured,":[95],"while":[96],"hepatic":[97,131,140,171,181],"malondialdehyde":[98],"(MDA),":[99],"reduced":[100,145],"glutathione":[101],"(GSH),":[102],"NRG4":[104,148,172,227],"levels":[105,149],"determined":[107],"using":[108,117],"ELISA-based":[109],"methods.":[110],"Histopathological":[111,174],"fibrosis":[113,184],"assessments":[114],"performed":[116],"hematoxylin":[118],"eosin":[120],"Masson's":[122],"trichrome":[123],"staining.":[124],"Results:":[125],"HFD":[127],"group":[128],"demonstrated":[129],"significant":[130],"injury,":[132],"characterised":[133],"by":[134,212],"increased":[135,170],"serum":[136],"ALT,":[137],"AST,":[138],"MDA":[141],"levels,":[142],"together":[143],"GSH":[146],"compared":[150],"control":[153],"group.":[154],"Treatment":[155],"significantly":[158],"improved":[159],"enzyme":[161],"profiles,":[162],"attenuated":[163],"oxidative":[164,206],"stress,":[165,207],"restored":[166],"antioxidant":[167],"status,":[168],"levels.":[173],"examination":[175],"revealed":[176],"marked":[178],"reduction":[179],"steatosis":[182],"rats,":[187],"comparable":[190],"those":[192],"observed":[193],"pioglitazone":[195],"treatment.":[196],"Conclusion:":[197],"Dapagliflozin":[198],"administration":[199],"was":[200],"associated":[201],"improvement":[203],"biochemical,":[205],"histopathological":[209],"alterations":[210],"induced":[211],"rats.":[217],"findings":[219],"are":[220,238],"consistent":[221],"potential":[224],"role":[225],"dapagliflozin;":[233],"however,":[234],"further":[235],"mechanistic":[236],"studies":[237],"required":[239],"clarify":[241],"underlying":[243],"molecular":[244],"pathways.":[245]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-11-01T00:00:00"}